Arrhythmias impair quality of life for over 5% of the world’s population. We believe that everyone should have access to diagnosis and management to enjoy an arrhythmia-free life.
We engage in a collaborative partnership with clinicians by offering innovative technologies that enable faster, easier procedures.
We foster innovation in a clinically experienced environment. We have a cross-disciplinary approach and an agile development team that supports clinical research and responds to customer feedback.
At Micropace, we began designing and manufacturing EP Cardiac Stimulators in 1995 and have grown to be world’s No. 1 supplier of EP Cardiac Stimulators worldwide.
Our company’s success stems from our intimate knowledge of clinical cardiac electrophysiology and its practitioner’s needs, guided by our founding CEO and practicing electrophysiologist, Dr Michael Cejnar, FRACP, allowing us to deliver products which are very easy to use and reliable, yet feature packed for the power user.
Dr Michael Cejnar is medical graduate of University of Sydney with a long career in clinical cardiology and interventional electrophysiology, the latter commencing in 1993 at Westmead Hospital under Professor David Ross, before going onto establishing and directing electrophysiology services at St George Public and Private Hospital, Kogarah, Sydney from 1996 until 2005.
He developed his first computerised EP stimulator, the EPS220 in 1996 to replace a Bloom DTU110 model with an easier and quicker to use device and established Micropace Pty Ltd, to manufacture and supply his colleague electrophysiologists around Australia with his stimulator via Bard Australia.
Micropace Pty Ltd started exporting its products to Europe and Asia in 1998 and entered the US Market in 2002 where its presence has grown in partnership with industry leaders such as Bard Electrophysiology, GE Healthcare and Atricure Inc. to become, 8 years later, the US market leader in EP stimulators.
In Feb 2007, Dr Cejnar founded the sister US company, Micropace EP, Inc, to support USA sales, raising the combined total employees to twenty. Today, Micropace family of stimulators exports into 42 countries, including USA, most European Union countries, Asia Pacific, India, Japan and China, with over 800 installation in the US and 1500 worldwide.